We showed in glioblastoma cells that therapeutically relevant doses (<50 μM) of TMZ are effective in activating the ATR/ATM-SIAH1/HIPK2-p53Ser46 axis and thus trigger apoptosis [45]. Here, SIAH1 is linked to glioblastoma.